OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors
Rachel H. Clare, Charlotte A. Dawson, Adam Westhorpe, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12
Rachel H. Clare, Charlotte A. Dawson, Adam Westhorpe, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12
Showing 12 citing articles:
Haemotoxicity of snakes: a review of pathogenesis, clinical manifestations, novel diagnostics and challenges in management
Bhawani Yasassri Alvitigala, Harsha Dissanayake, Praveen Weeratunga, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2025)
Open Access | Times Cited: 2
Bhawani Yasassri Alvitigala, Harsha Dissanayake, Praveen Weeratunga, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2025)
Open Access | Times Cited: 2
Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults
Michael Abouyannis, Yvonne K. Nyambura, Samson Ngome, et al.
EBioMedicine (2025) Vol. 113, pp. 105600-105600
Open Access | Times Cited: 1
Michael Abouyannis, Yvonne K. Nyambura, Samson Ngome, et al.
EBioMedicine (2025) Vol. 113, pp. 105600-105600
Open Access | Times Cited: 1
Optimizing drug discovery for snakebite envenoming via a high-throughput phospholipase A2 screening platform
Laura-Oana Albulescu, Adam Westhorpe, Rachel H. Clare, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
Laura-Oana Albulescu, Adam Westhorpe, Rachel H. Clare, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortages
Gabriela Solano, Sinead Cunningham, Rebecca J. Edge, et al.
BMJ Global Health (2024) Vol. 9, Iss. 3, pp. e014813-e014813
Open Access | Times Cited: 4
Gabriela Solano, Sinead Cunningham, Rebecca J. Edge, et al.
BMJ Global Health (2024) Vol. 9, Iss. 3, pp. e014813-e014813
Open Access | Times Cited: 4
A review on NLRP3 inflammasome modulation by animal venom proteins/peptides: mechanisms and therapeutic insights
Akshad Balde, Soottawat Benjakul, Rasool Abdul Nazeer
Inflammopharmacology (2025)
Closed Access
Akshad Balde, Soottawat Benjakul, Rasool Abdul Nazeer
Inflammopharmacology (2025)
Closed Access
Innovations in Snake Venom-Derived Therapeutics: A Systematic Review of Global Patents and Their Pharmacological Applications
Diana Carolina Zona Rubio, Diana Marcela Aragón, Izabel Almeida Alves
Toxins (2025) Vol. 17, Iss. 3, pp. 136-136
Open Access
Diana Carolina Zona Rubio, Diana Marcela Aragón, Izabel Almeida Alves
Toxins (2025) Vol. 17, Iss. 3, pp. 136-136
Open Access
Electrical Cell Impedance Sensing (ECIS): Feasibility of a Novel In Vitro Approach to Studying Venom Toxicity and Potential Therapeutics
Aniruddha Choudhury, Kaitlin Linne, Tommaso C. Bulfone, et al.
Toxins (2025) Vol. 17, Iss. 4, pp. 193-193
Open Access
Aniruddha Choudhury, Kaitlin Linne, Tommaso C. Bulfone, et al.
Toxins (2025) Vol. 17, Iss. 4, pp. 193-193
Open Access
Practical progress towards the development of recombinant antivenoms for snakebite envenoming
Stefanie K. Menzies, Rohit N. Patel, Stuart Ainsworth
Expert Opinion on Drug Discovery (2025), pp. 1-21
Open Access
Stefanie K. Menzies, Rohit N. Patel, Stuart Ainsworth
Expert Opinion on Drug Discovery (2025), pp. 1-21
Open Access
Enhancing Snakebite Management: The Role of Small Molecule Therapeutics in Complementing Antivenom Strategies
Grasiela Mariano Silva, Abhinandan Chowdhury
Toxicon (2024) Vol. 249, pp. 108081-108081
Closed Access | Times Cited: 3
Grasiela Mariano Silva, Abhinandan Chowdhury
Toxicon (2024) Vol. 249, pp. 108081-108081
Closed Access | Times Cited: 3
Dimethyl ester of bilirubin ameliorates Naja naja snake venom-induced lung toxicity in mice via inhibiting NLRP3 inflammasome and MAPKs activation.
Manuganahalli B. Nandana, Madeva Bharatha, Raju Praveen, et al.
Toxicon (2024) Vol. 244, pp. 107757-107757
Closed Access | Times Cited: 2
Manuganahalli B. Nandana, Madeva Bharatha, Raju Praveen, et al.
Toxicon (2024) Vol. 244, pp. 107757-107757
Closed Access | Times Cited: 2
Qualitative Profiling of Venom Toxins in the Venoms of Several Bothrops Species Using High-Throughput Venomics and Coagulation Bioassaying
Dimoetsha J. C. Weekers, Luis L. Alonso, Anniek X. Verstegen, et al.
Toxins (2024) Vol. 16, Iss. 7, pp. 300-300
Open Access | Times Cited: 2
Dimoetsha J. C. Weekers, Luis L. Alonso, Anniek X. Verstegen, et al.
Toxins (2024) Vol. 16, Iss. 7, pp. 300-300
Open Access | Times Cited: 2
Metabolomics‐driven approaches for identifying therapeutic targets in drug discovery
Sophearith Pan, Lichang Yin, Jie Liu, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 2
Sophearith Pan, Lichang Yin, Jie Liu, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 2
Development of An Optimised Oral Regimen of Unithiol for the Treatment of Snakebite Envenoming: a Phase 1 Dose-Escalation Trial and Pharmacokinetic Analysis in Healthy Kenyan Adults
Michael Abouyannis, Yvonne K. Nyambura, Samson Ngome, et al.
(2024)
Closed Access | Times Cited: 1
Michael Abouyannis, Yvonne K. Nyambura, Samson Ngome, et al.
(2024)
Closed Access | Times Cited: 1
